TSNLF (Tristel) Other Stockholders Equity: $2.08 Mil (As of Dec. 2025)


TSNLF Tristel PLC TSNLF
97 GF Score
Price $5.53
GF Value $6.07
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Tristel Other Stockholders Equity?

Tristel TSNLF +6.35% 97 Other Stockholders Equity is $2.08 Mil as of Dec. 2025. GuruFocus rates TSNLF with a GF Score™ of 97/100 and a GF Value™ of $6.07 (Fairly Valued). The stock has 1 warning sign investors should review.

Tristel's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $2.08 Mil.

Tristel's quarterly Other Stockholders Equity increased from Dec. 2024 ($1.51 Mil) to Jun. 2025 ($1.91 Mil) and increased from Jun. 2025 ($1.91 Mil) to Dec. 2025 ($2.08 Mil).

Tristel's annual Other Stockholders Equity declined from Jun. 2023 ($2.43 Mil) to Jun. 2024 ($1.98 Mil) and declined from Jun. 2024 ($1.98 Mil) to Jun. 2025 ($1.91 Mil).

Tristel Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Tristel's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tristel Other Stockholders Equity Chart

Tristel Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.81 2.64 2.43 1.98 1.91

Tristel Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.52 1.98 1.51 1.91 2.08
TSNLF
97GF Score
Tristel PLC TSNLF
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tristel Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $2.08 Mil mean?
Tristel (TSNLF) has a Other Stockholders Equity of $2.08 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Tristel and its competitors.
Is Tristel's Other Stockholders Equity too high?
Tristel's current Other Stockholders Equity is $2.08 Mil. Overall, Tristel has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tristel's Other Stockholders Equity compare to ISRG and BDX?
Tristel's Other Stockholders Equity of $2.08 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Tristel and its competitors. Tristel's current Other Stockholders Equity is $2.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tristel stock overvalued right now?
Based on GuruFocus' analysis, Tristel (TSNLF) is currently considered Fairly Valued. The stock's GF Value™ is $6.07, compared to a current price of $5.53 — trading 8.9% below its estimated fair value. The current Other Stockholders Equity is $2.08 Mil. Tristel's overall GF Score™ is 97/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Tristel (TSNLF), the current Other Stockholders Equity is $2.08 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tristel (TSNLF) Overvalued in 2026?

Based on GuruFocus' analysis, Tristel stock appears to be undervalued. The current stock price of $5.53 is trading 8.9% below its estimated GF Value™ of $6.07. GuruFocus considers Tristel to be Fairly Valued.

Key valuation signals for TSNLF:

  • Other Stockholders Equity: $2.08 Mil
  • GF Value™: $6.07 vs. price of $5.53 (8.9% below fair value)
  • GF Score™: 97/100 with 1 warning sign

No single metric tells the full story. See the TSNLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tristel Business Description

Other Exchanges TSTL:UKR1V:Germany
Address Fordham Road, Unit 1B, Lynx Business Park, Newmarket, Snailwell, Cambridgeshire, GBR, CB8 7NY
Tristel PLC's business is the sale to hospitals of its proprietary chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand and for the sporicidal disinfection of environmental surfaces under the Cache brand. Its operating segments include hospital medical device decontamination products used predominantly for infection control in hospitals; the manufacture and sale of hospital environmental surface disinfection products; and pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare. The company generates the majority of its revenue from hospital medical device decontamination and operates geographically in the UK and overseas markets.
97GF Score

Get the complete analysis for TSNLF

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.53
Price
$6.07
GF Value